Frontlight ResearchEarly access
SuspendedNo phase
Omnibond vs Dermabond
Key facts
- Who runs it
- Center for Innovation and Research Organization
- Where
- New Albany, New York, Philadelphia, and Providence, United StatesSee the 4 sites
- Trial code
- Status
- Suspended
- People taking part
- 310 people, planned
- Started
- 25 Oct 2022
- Ended
- Feb 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Omnibond Topical Skin Adhesive
- Dermabond Advanced Topical Skin Adhesive
- Record updated
- 7 February 2024
- Why it stopped
- Temporarily halted
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patient ≥18 years old
- Male or non-pregnant, non-lactating, postmenopausal or surgically sterilized females
- Subjects scheduled to undergo primary, elective total knee arthroplasty or total hip arthroplasty
- Subjects provide informed consent, which will consist of reading, signing, and dating the informed consent document after the Investigator, sub-Investigator or other designated study staff member has explained the study procedures, risks, and contact information
- Subjects deemed able to understand and comply with study visit schedule and procedures
Who cannot take part
- Active or previous infection in the skin or the knee or hip to be operated, evidence of gangrene
- Subjects who have participated in this trial previously and who were withdrawn
- Local skin conditions such as dermatitis, eczema, psoriasis that, in the opinion of the investigator, will make it difficult to assess wound complications or local skin reactions following surgery
- Subjects with known allergies to product components including cyanoacrylate, formaldehyde, benzalkonium chloride or have known allergies or skin sensitivity to the Convatec Aquacel dressing
- Pregnant, lactating females, or females of childbearing potential not willing to practice an effective method of contraception
- Inability or refusal to provide informed consent or follow study and wound care instructions
Where in United States
- JIS OrthopaedicsNew Albany, United States
- Columbia UniversityNew York, United States
- Rothman Orthopaedic InstitutePhiladelphia, United States
- Rhode Island HospitalProvidence, United States
About the trial
What the trial wants to find out
This prospective, randomized, controlled, blinded clinical trial is designed to assess the incidence of all time and all types of wound-related complications following total joint arthroplasty (TJA) when two different types of topical skin adhesives are used to close the incision.
The 2 groups in the trial
- Omnibond topical skin adhesiveExisting treatment, for comparison
- Dermabond topical skin adhesiveExisting treatment, for comparison
Treatment: Dermabond Advanced Topical Skin Adhesive
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Randomized, Single-blinded Study to Assess the Incidence of Wound Complications Following Total Knee and Hip Arthroplasty in Patients Treated With Two Different Types of Topical Skin Adhesive
- Record updated
- 7 February 2024